Bloomsbury Genetic Therapies launches with Seed financing of £5 million to develop potentially curative gene therapy treatments for rare neurological and metabolic diseasesLondon, UK, 7 October 2022 – Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a biotechnology company developin.